.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Citi
Accenture
Novartis
Farmers Insurance
Harvard Business School
Fuji
US Army
Chubb
Federal Trade Commission

Generated: July 22, 2017

DrugPatentWatch Database Preview

UROVIST MEGLUMINE DIU/CT Drug Profile

« Back to Dashboard

What is the patent landscape for Urovist Meglumine Diu/ct, and what generic Urovist Meglumine Diu/ct alternatives are available?

Urovist Meglumine Diu/ct is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in UROVIST MEGLUMINE DIU/CT is diatrizoate meglumine. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.

Summary for Tradename: UROVIST MEGLUMINE DIU/CT

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list12
Clinical Trials: see list32
Patent Applications: see list736
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:UROVIST MEGLUMINE DIU/CT at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare
UROVIST MEGLUMINE DIU/CT
diatrizoate meglumine
INJECTABLE;INJECTION087739-001Sep 23, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Novartis
Fuji
UBS
Express Scripts
AstraZeneca
Chinese Patent Office
Covington
Baxter
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot